Vaxcyte is a vaccine innovation company focused on developing broad-spectrum conjugate and protein vaccines to prevent and treat bacterial infectious diseases. Using advanced synthetic techniques and the XpressCF™ platform, Vaxcyte aims to create high-fidelity vaccines with enhanced immunological benefits, with candidates like VAX-24 for pneumococcal disease and VAX-A1 for Group A Strep.
Vaxcyte Highlights:
Overview
- Website: vaxcyte.com
- Headquarters: San Carlos, California
- Employees: 380
- Founded: 2013
- Email: info@vaxcyte.com
- Funding: $1.5B
- Revenue: $575.2M
- Valuation: n/a
Contacts
- Email: ***@vaxcyte.com
Similar companies
Frequently Asked Questions related to Vaxcyte
Vaxcyte is located in San Carlos, California.
Yes, Vaxcyte is a Silicon Valley company.
Vaxcyte total funding is 1.5B.
Vaxcyte revenue is 575.2M.
Vaxcyte’s number of employees is 380.
Vaxcyte’s CEO name is Annette Makarewycz.
Vaxcyte was founded in 2013.
Vaxcyte’s contact email is info@vaxcyte.com.
